# Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease

Study · id `cardio:ct-nct03318276` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03318276](<https://clinicaltrials.gov/study/NCT03318276>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03318276

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 170 participants.

## Technical summary

Registry record NCT03318276. Randomized; triple masking; primary purpose treatment. Start 2017-02-20 (actual); primary completion 2018-10-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 170 participants (enrolled count; ClinicalTrials.gov record NCT03318276, source copy `cardio:ctgov-nct03318276-2019-09-20`, retrieved 2026-10-31)
- Started: 2017-02-20 (actual) (ClinicalTrials.gov record NCT03318276, source copy `cardio:ctgov-nct03318276-2019-09-20`, retrieved 2026-10-31)
- Primary completion: 2018-10-15 (actual) (ClinicalTrials.gov record NCT03318276, source copy `cardio:ctgov-nct03318276-2019-09-20`, retrieved 2026-10-31)
- Completion: 2018-10-15 (actual) (ClinicalTrials.gov record NCT03318276, source copy `cardio:ctgov-nct03318276-2019-09-20`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT03318276, source copy `cardio:ctgov-nct03318276-2019-09-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03318276-2019-09-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease
- Condition: Peripheral Arterial Disease
- Intervention (Drug): SID142
- Intervention (Drug): Rinexin® Tab
- Lead sponsor: SK Chemicals Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: SK Chemicals Co., Ltd. (`cardio:org-sk-chemicals-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial (`cardio:pubmed-35410753`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 42ca0c96e1df976f88ae5a424234c20998bcb4fb5630ca00c0027bca64e7bfc7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
